{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:47Z","timestamp":1793225327184,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-017"],"award-info":[{"award-number":["2022-PUMCH-C-017"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507204"],"award-info":[{"award-number":["2023YFC2507204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03736-4","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:34:18Z","timestamp":1748518458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance of anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonia: a retrospective observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"3736_CR1","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318:1651\u20137.","journal-title":"N Engl J Med"},{"key":"3736_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"3736_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0025-6196(12)62575-0","volume":"65","author":"AK Nada","year":"1990","unstructured":"Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary Fibrosis as an Unusual Clinical Manifestation of a Pulmonary-Renal Vasculitis in Elderly Patients. Mayo Clin Proc. 1990;65:847\u201356.","journal-title":"Mayo Clin Proc"},{"key":"3736_CR4","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar4550","volume":"16","author":"KE Sada","year":"2014","unstructured":"Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16:R101\u2013201.","journal-title":"Arthritis Res Ther"},{"key":"3736_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Crestani B, Tazi A, Hervier B, Adam-Marchand S, Nunes H, et al. Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature. Medicine. 2014;93:340\u20139.","journal-title":"Medicine"},{"key":"3736_CR6","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.chest.2021.01.083","volume":"159","author":"H Hozumi","year":"2021","unstructured":"Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, et al. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis. Chest. 2021;159:2334\u201345.","journal-title":"Chest"},{"key":"3736_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","volume":"102","author":"G Foulon","year":"2008","unstructured":"Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP, Brauner M, et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med. 2008;102:1392\u20138.","journal-title":"Respir Med"},{"key":"3736_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/resp.12763","volume":"21","author":"C Hosoda","year":"2016","unstructured":"Hosoda C, Baba T, Hagiwara E, Ito H, Matsuo N, Kitamura H, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology. 2016;21:920\u20136.","journal-title":"Respirology"},{"key":"3736_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.rmed.2012.08.024","volume":"106","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Otani K, Egashira R, Kashima Y, Taniguchi H, Kondoh Y, et al. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. Respir Med. 2012;106:1765\u201370.","journal-title":"Respir Med"},{"key":"3736_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000183754","volume":"77","author":"T Nozu","year":"2009","unstructured":"Nozu T, Kondo M, Suzuki K, Tamaoki J, Nagai A. A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration. 2009;77:407\u201315.","journal-title":"Respiration"},{"key":"3736_CR11","doi-asserted-by":"crossref","unstructured":"Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, et al. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019;156:715-23.","DOI":"10.1016\/j.chest.2019.05.014"},{"key":"3736_CR12","doi-asserted-by":"publisher","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","volume":"2","author":"N Kagiyama","year":"2015","unstructured":"Kagiyama N, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2015;2:e000058.","journal-title":"BMJ Open Respir Res"},{"key":"3736_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","volume":"107","author":"M Ando","year":"2013","unstructured":"Ando M, Miyazaki E, Ishii T, Mukai Y, Yamasue M, Fujisaki H, et al. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013;107:608\u201315.","journal-title":"Respir Med"},{"key":"3736_CR14","doi-asserted-by":"publisher","first-page":"175346662211409","DOI":"10.1177\/17534666221140974","volume":"16","author":"T Wu","year":"2022","unstructured":"Wu T, Zhang Y, Cen Z, Ying Y, Sun C, Lv C, et al. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis. Ther Adv Respir Dis. 2022;16:17534666221140974.","journal-title":"Ther Adv Respir Dis"},{"key":"3736_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12890-021-01451-4","volume":"21","author":"X Sun","year":"2021","unstructured":"Sun X, Peng M, Zhang T, Li Z, Song L, Li M, et al. Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody. BMC Pulm Med. 2021;21:88.","journal-title":"BMC Pulm Med"},{"key":"3736_CR16","doi-asserted-by":"crossref","unstructured":"Hozumi H, Oyama Y, Yasui H, Suzuki Y, Kono M, Karayama M, et al. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. Plos One. 2018;13:e0199659.","DOI":"10.1371\/journal.pone.0199659"},{"key":"3736_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1183\/09031936.00148409","volume":"37","author":"P Guilpain","year":"2011","unstructured":"Guilpain P, Ch\u00e9reau C, Goulvestre C, Servettaz A, Montani D, Tamas N, et al. The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J. 2011;37:1503.","journal-title":"Eur Respir J"},{"key":"3736_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014;233:294\u2013307.","journal-title":"J Pathol"},{"key":"3736_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.autrev.2019.06.011","volume":"18","author":"E Frangou","year":"2019","unstructured":"Frangou E, Vassilopoulos D, Boletis J, Boumpas DT. An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment. Autoimmun Rev. 2019;18:751\u201360.","journal-title":"Autoimmun Rev"},{"key":"3736_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1055\/s-0038-1669914","volume":"39","author":"R Borie","year":"2018","unstructured":"Borie R, Crestani B. Antineutrophil Cytoplasmic Antibody-Associated Lung Fibrosis. Seminars in Respiratory and Critical Care Medicine. 2018;39:465\u201370.","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"3736_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1183\/09031936.00110109","volume":"36","author":"GE Tzelepis","year":"2009","unstructured":"Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J. 2009;36:116\u201321.","journal-title":"Eur Respir J"},{"key":"3736_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1165\/rcmb.4791","volume":"27","author":"A Churg","year":"2002","unstructured":"Churg A, Zay K, Shay S, Xie C, Shapiro SD, Hendricks R, et al. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am J Respir Cell Mol Biol. 2002;27:368\u201374.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3736_CR23","doi-asserted-by":"publisher","first-page":"190321","DOI":"10.1183\/20734735.0321-2019","volume":"16","author":"G Suarez-Cuartin","year":"2020","unstructured":"Suarez-Cuartin G, Molina-Molina M. Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients. Breathe (Sheff). 2020;16:190321.","journal-title":"Breathe (Sheff)"},{"key":"3736_CR24","doi-asserted-by":"crossref","unstructured":"Libra A, Muscato G, Ielo G, Spicuzza L, Palmucci S, Fagone E, et al. Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study. Diagnostics (Basel). 2023;13:1882.","DOI":"10.3390\/diagnostics13111882"},{"key":"3736_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00408-016-9851-x","volume":"194","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Enomoto N, Oyama Y, Kono M, Fujisawa T, Inui N, et al. Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias. Lung. 2016;194:235\u201342.","journal-title":"Lung"},{"key":"3736_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3346\/jkms.2013.28.5.731","volume":"28","author":"BH Kang","year":"2013","unstructured":"Kang BH, Park JK, Roh JH, Song JW, Lee CK, Kim M, et al. Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia. J Korean Med Sci. 2013;28:731\u20137.","journal-title":"J Korean Med Sci"},{"key":"3736_CR27","first-page":"101111","volume":"86","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zhou C, Sun X, Xue P, Li Z, Zhang W, et al. Interstitial lung diseases associated with ANCA positivity: A different disease spectrum from interstitial pneumonia with autoimmune features. Respir Med Res. 2024;86:101111.","journal-title":"Respir Med Res"},{"key":"3736_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al. An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46:976\u201387.","journal-title":"Eur Respir J"},{"key":"3736_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"3736_CR30","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"3736_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","volume":"13","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Su\u00e1rez LF, Guillevin L, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13:683\u201392.","journal-title":"Nat Rev Rheumatol"},{"key":"3736_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","volume":"81","author":"R Suppiah","year":"2022","unstructured":"Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81:321\u20136.","journal-title":"Ann Rheum Dis"},{"key":"3736_CR33","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1055\/s-0042-1755563","volume":"43","author":"K Rodriguez","year":"2022","unstructured":"Rodriguez K, Ashby CL, Varela VR, Sharma A. High-Resolution Computed Tomography of Fibrotic Interstitial Lung Disease. Semin Respir Crit Care Med. 2022;43:764\u201379.","journal-title":"Semin Respir Crit Care Med"},{"key":"3736_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61:718\u201322.","journal-title":"Ann Rheum Dis"},{"key":"3736_CR35","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, et al. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial. JAMA. 2021;325:2178\u201387.","journal-title":"JAMA"},{"key":"3736_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83:30\u201347.","journal-title":"Ann Rheum Dis"},{"key":"3736_CR37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/rccm.200211-1311OC","volume":"168","author":"HR Collard","year":"2003","unstructured":"Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"3736_CR38","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1513\/AnnalsATS.201606-458OC","volume":"14","author":"MO Paterniti","year":"2017","unstructured":"Paterniti MO, Bi Y, Reki\u0107 D, Wang Y, Karimi-Shah BA, Chowdhury BA. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2017;14:1395\u2013402.","journal-title":"Ann Am Thorac Soc"},{"key":"3736_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12890-019-0943-2","volume":"19","author":"C Chan","year":"2019","unstructured":"Chan C, Ryerson CJ, Dunne JV, Wilcox PG. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study. BMC Pulm Med. 2019;19:192.","journal-title":"BMC Pulm Med"},{"key":"3736_CR40","doi-asserted-by":"publisher","first-page":"17616","DOI":"10.1038\/s41598-023-45027-0","volume":"13","author":"S Sakamoto","year":"2023","unstructured":"Sakamoto S, Suzuki A, Homma S, Usui Y, Shimizu H, Sekiya M, et al. Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease. Sci Rep. 2023;13:17616.","journal-title":"Sci Rep"},{"key":"3736_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","volume":"160","author":"P Foucher","year":"1999","unstructured":"Foucher P, Heeringa P, Petersen AH, Huitema MG, Brouwer E, Tervaert JW, et al. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med. 1999;160:987\u201394.","journal-title":"Am J Respir Crit Care Med."},{"key":"3736_CR42","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990;87:4115\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3736_CR43","doi-asserted-by":"publisher","first-page":"102781","DOI":"10.1016\/j.autrev.2021.102781","volume":"20","author":"M Negreros","year":"2021","unstructured":"Negreros M, Flores-Su\u00e1rez LF. A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis. Autoimmun Rev. 2021;20:102781.","journal-title":"Autoimmun Rev"},{"key":"3736_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0891-5849(96)00327-9","volume":"22","author":"G Poli","year":"1997","unstructured":"Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997;22:287\u2013305.","journal-title":"Free Radic Biol Med"},{"key":"3736_CR45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/nep.12736","volume":"21","author":"M Yoshida","year":"2016","unstructured":"Yoshida M, Yamada M, Sudo Y, Kojima T, Tomiyasu T, Yoshikawa N, et al. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis. Nephrology (Carlton). 2016;21:624\u20139.","journal-title":"Nephrology (Carlton)"},{"key":"3736_CR46","doi-asserted-by":"crossref","unstructured":"Kadura S, Raghu G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review. Eur Respir Rev. 2021;30:210123.","DOI":"10.1183\/16000617.0123-2021"},{"key":"3736_CR47","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med. 2015;192:e3-19.","journal-title":"Am J Respir Crit Care Med."},{"key":"3736_CR48","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.42075","volume":"74","author":"EL Matteson","year":"2022","unstructured":"Matteson EL, Kelly C, Distler JHW, Hoffmann-Vold AM, Seibold JR, Mittoo S, et al. Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial. Arthritis Rheumatol. 2022;74:1039\u201347.","journal-title":"Arthritis Rheumatol"},{"key":"3736_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020;8:147\u201357.","journal-title":"Lancet Respir Med"},{"key":"3736_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12890-019-0937-0","volume":"19","author":"SE Torrisi","year":"2019","unstructured":"Torrisi SE, Kahn N, W\u00e4lscher J, Sarmand N, Polke M, Lars K, et al. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. BMC Pulm Med. 2019;19:213.","journal-title":"BMC Pulm Med"},{"key":"3736_CR51","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccm.2019.05.012","volume":"40","author":"GE Thompson","year":"2019","unstructured":"Thompson GE, Specks U. Update on the Management of Respiratory Manifestations of the Antineutrophil Cytoplasmic Antibodies-Associated Vasculitides. Clin Chest Med. 2019;40:573\u201382.","journal-title":"Clin Chest Med"},{"key":"3736_CR52","doi-asserted-by":"crossref","unstructured":"Yamakawa H, Toyoda Y, Baba T, Kishaba T, Fukuda T, Takemura T, et al. Anti-Inflammatory and\/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. J Clin Med. 2022;11:3835.","DOI":"10.3390\/jcm11133835"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03736-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:03:02Z","timestamp":1748523782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3736"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03736-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Peking Union Medical College Hospital Institutional Review Board (Reference number: S-634). Written informed consent from study subjects was waived because of the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}